AZ11557272, a dual MMP-9 and MMP-12 inhibitor, abolishes smoke-induced lavage inflammatory cells and serum tumor necrosis factor α (TNFα), ameliorates morphological emphysema targets of COPD, and participates in the therapeutic process [43]. The gene discussed is TNF; the disease is chronic obstructive pulmonary disease.